Table 1.
The clinical information in the three pSS-related datasets
| GSE51092 | GSE66795 | GSE84844 | Overall | |
|---|---|---|---|---|
| (N = 222) | (N = 160) | (N = 60) | (N = 442) | |
| Group | ||||
| Control | 32 (14.4%) | 29 (18.1%) | 30 (50.0%) | 91 (20.6%) |
| pSS | 190 (85.6%) | 131 (81.9%) | 30 (50.0%) | 351 (79.4%) |
| Age | ||||
| [20, 30] | 0 (0%) | 0 (0%) | 7 (11.7%) | 7 (1.6%) |
| [30, 40] | 0 (0%) | 0 (0%) | 10 (16.7%) | 10 (2.3%) |
| [40, 50] | 0 (0%) | 0 (0%) | 15 (25.0%) | 15 (3.4%) |
| [50, 60] | 0 (0%) | 0 (0%) | 10 (16.7%) | 10 (2.3%) |
| [60, 70] | 0 (0%) | 0 (0%) | 12 (20.0%) | 12 (2.7%) |
| [70, 80] | 0 (0%) | 0 (0%) | 6 (10.0%) | 6 (1.4%) |
| Missing | 222 (100%) | 160 (100%) | 0 (0%) | 382 (86.4%) |
| Gender | ||||
| Female | 0 (0%) | 160 (100%) | 59 (98.3%) | 219 (49.5%) |
| Male | 0 (0%) | 0 (0%) | 1 (1.7%) | 1 (0.2%) |
| Missing | 222 (100%) | 0 (0%) | 0 (0%) | 222 (50.2%) |